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Sunday, February 26, 2012 137awere normalized to the transcript level of the housekeeping gene GAPD. With-
out normalization no correlation was obtained, indicating that cell-to-cell var-
iability in mRNA isolation represents most of the experimental noise. This
improved technique should prove very valuable for studying the molecular
background of diversity in excitability in normal and disease conditions.
Support: FWO-G.0449.11, BOF-GOA-2004-University of Antwerp
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Controlling neuronal excitability with light has emerged as a powerful and
widely used approach in Neuroscience. Optogenetic tools function by enabling
light to activate exogenously expressed ion channels that over-power endoge-
nous electrophysiogical processes.
In contrast, we have introduced a non-genetic approach to conferring light sen-
sitivity on neurons that involves photochemical tools that regulate endogenous
ion channels. Specifically, the design of the molecule QAQ is built around an
azobenzene photoswitch group flanked by two symmetric quaternary ammo-
nium groups which confer the ability to intracellularly block voltage-gated so-
dium, potassium and calcium channels. Blocking can be regulated by rapid and
reversible photoisomerization of the central azobenzene group from trans to cis
configuration upon 380 or 500nm light illumination, respectively. QAQ in its
trans configuration blocks ion conduction through open channels enabling
light-sensitive silencing of neurons while conversion to the cis configuration re-
lieves the block.
Given its double-charged character, QAQ is membrane-impermeable but it can
enter cells through TRPV1 or P2X7 receptors if they are active. Since TRPV1 is
mainly expressed in dorsal root ganglia neurons and participates in the percep-
tion of various external stimuli and pain, QAQ functions as a local anesthetic
inhibiting neuronal excitibitly after cell entry.
In that context, we have demonstrated that QAQ can modify nociception after
selective loading of active pain neurons. However, the precise biophysical
mechanism of action of QAQ on voltage-gated channels remains unclear.
Therefore, we conducted an extended biophysical characterization using ex-
cised inside-out patches to elucidate binding characteristics of both QAQ con-
figurations on a reporter channel, the voltage-gated potassium channel Shaker.
Experiments involving mutations of Shaker and monitoring of QAQ trapping
upon gate closure revealed interactions of QAQ with the channel. In summary,
we examined the state-dependent persistence of blocking and our findings lead
to multi-state binding model.
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Intracellular sodium regulated Slo2.1 channels are selectively expressed in the
brain and the heart. They are closed under normal physiological and ionic con-
ditions, but markedly activated after elevation of [Naþ]i, for example during
myocardial ischemia. These channels are also activated by fenamates without
elevation of intracellular sodium. Fenamates (N-arylated derivatives of anthra-
nilic acid with different substituents on the aryl ring) are non-steroidal anti-
inflammatory drugs that function as mixed agonists for Slo2.1 channels. We
performed Quantitative Structure Activity Relationship (QSAR) studies on
these drugs and established the requirement of a minimal pharmacophore de-
fined as fenamic acid (2-(phenylamino) benzoic acid) for Slo2.1 channel acti-
vation. Meclofenamic acid was found to be the most potent activator of Slo2.1
channels expressed in Xenopus oocytes with an EC50 of 90 mM. We further re-
port that verapamil, an open-state dependent blocker, blocks Slo2.1 (IC50 = 15
mM) and has free access to its binding site even in the non-activated state of the
channel. The permanently charged, membrane impermeant analogue of verap-
amil, D890 was used to address sidedness of block and location of the binding
site in the channel protein. These observations indicate that unlike other potas-
sium channels, the canonical S6 bundle crossing in Slo2.1 channels is always in
an open configuration and does not function as the primary activation gate.
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We demonstrated that the CRAC domain nearest the N-end of BK channel-
forming cbv1 subunits (CRAC4) is the main region that provides cholesterol(CLR) sensitivity to cbv1, the signature CRAC4 Y450 being critical. Here
we combined amino acid substitutions in CRAC4, bilayer electrophysiology,
and computational dynamics to advance structural bases of CRAC4-CLR inter-
actions. First, trcbv1-CRAC4 constructs including V444A or K453A were in-
sensitive to CLR. Second, trcbv1-CRAC4 K453R retained CLR sensitivity.
Third, trcbv1-CRAC4 Y450F was CLR-resistant. However, Y429F in the S6-
CRAC4 linker rendered CLR-sensitive channels. Therefore, CLR sensitivity
of trcbv1-CRAC4 is determined by the key residues that define a CRAC motif
(Epand, 2006). Moreover, the substitution Y450F in CRAC4 was sufficient to
blunt the CLR sensitivity of full-length BK channels. Computational simula-
tions of full-length cbv1 CTD and trcbv1 CTD-CRAC4 showed CLR remain-
ing in CRAC4 for the majority of the simulation with CLRD ring near Y450 for
over one-third of the simulation. CLR A ring resided predominantly near E417,
which hydrogen bonded with CRAC4 through the Y450 hydroxyl, also indicat-
ing that CLR stayed close to CRAC4. Conversely, the highest residence for
trcbv1 CTD-CRAC4 Y450F was for CLR D ring and tail, which remained
near H409 and Y336, respectively, neither of which are part of CRAC4. Nota-
bly higher mobility of positions 450 and K453 in CRAC4 were also noted in the
simulations of trcbv1-CRAC4 Y450F, indicating that a stable interaction site
for CLR is lacking when the Y450 hydroxyl is not present to hydrogen bond
to E417. Data provide a structural interpretation for the prominence of
CRAC4 and its Y450 in providing CLR-sensitivity to trcbv1-CRAC4 and
full-length BK channels. Support: R01-HL104631;R37-AA011560 (AMD);
UTHSC NI Fellowship (AKS).
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In neurons, b2-adrenergic (b2AR) enhancement of the activity of L-type
voltage-gated calcium channels (Cav1.2) is important for certain forms of syn-
aptic plasticity. The mechanism of regulation is thought to involve phosphory-
lation by protein kinase A (PKA) of residues in the C-terminus of Cav1.2. A
PKA-anchoring protein (AKAP) is required for efficient phosphorylation and
enhancement of Cav1.2 channel activity. Neuronally-localized AKAP79, un-
like all other AKAPs, binds the Ca2þ/calmodulin-activated phosphatase calci-
neurin (CaN), and thus anchors CaN along with PKA within the Cav1.2-b2AR
complex. To study b2AR enhancement of Cav1.2 channel activity, we have
used whole-cell patch-clamp to voltage-clamp currents from tsA-201 cells
transfected with constructs for full-length Cav1.2, the channel’s accessory sub-
units (b2b, a2d), AKAP79 and the b2AR. With this system, we have found that
b2AR agonist (isoproterenol, Iso) can enhance Ba
2þ current ~25%. Enhance-
ment by Iso was nearly absent (~5%) when current was carried by Ca2þ. Can-
didates that could support Ca2þ-dependent suppression of enhancement include
CaN and the Ca2þ/calmodulin-dependent kinase CaMKII, which is also scaf-
folded to the channel. Sites phosphorylated by PKA and suspected of involve-
ment in enhancement include residues S1700, T1704 and S1928 in the CaV1.2
C-terminus. Substitution of alanine at any of these three sites of phosphoryla-
tion by PKA abolished enhancement by Iso. To further investigate the mecha-
nism of enhancement, we used the ratio of Ba2þ tail current (60 mV) to gating
charge at reversal as an index of the efficiency of channel opening (Itail/Qgate
coupling efficiency). For wild-type (WT) channels, coupling efficiency was in-
creased by Iso. Phosphorylation site mutations (S1700, S1928, S1700þT1704)
decreased coupling efficiency in the absence of Iso, and abolished the Iso-
induced increase in coupling efficiency observed for WT channels, consistent
with the inability of agonist to enhance current carried by the mutants.
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Hindlimb unloading (HU)-induced muscle disuse is characterized by atrophy
and slow-to-fast phenotype shift of slow-twitch soleus muscle (Sol), including
adaptation of sarcolemma ion channel expression and function. Pleiotrophin
(PTN) is an heparin-binding growth factor produced also by muscle with proan-
giogenic, neurotrophic, and postsynaptic action. Here we evaluate the effects of
PTN on Sol properties after 14-days HU using PTN-overexpressing mice. After
